• Potassium Supplementation and the Prevention of Afib After Cardiac Surgery: TiGHT-K Trial

  • Oct 15 2024
  • Length: 9 mins
  • Podcast

Potassium Supplementation and the Prevention of Afib After Cardiac Surgery: TiGHT-K Trial

  • Summary

  • The goal of the TIGHT K trial was to evaluate if prescribing relaxed control of potassium levels and only giving supplements in the rare event that levels became pathologically low was equally as effective in preventing atrial fibrillation (AFib) after cardiac surgery as tightly controlling levels. In this interview, Drs. Steven Nissen and Benjamin O’Brien discuss the TIGHT K trial results which proved that practitioners can safely cease the widespread practice of maintaining high-normal potassium levels after isolated coronary artery bypass grafting surgery. Additional benefits include improved tpatient experience and reduced patient cost. References: O’Brien B, Campbell NG, Allen E, et al; TIGHT K Investigators. Potassium supplementation and prevention of atrial fibrillation after cardiac surgery: the TIGHT K randomized clinical trial. JAMA 2024;332:979-88. Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL
    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Potassium Supplementation and the Prevention of Afib After Cardiac Surgery: TiGHT-K Trial

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.